# Pipeline

We are developing next-generation immunotherapies guided towards clinical success by our single-cell DIS® translational platform.

## Programs

- **EMUNKITUG (HFB200301)**  
- **HFB200603**  
- **NUVUSTOTUG (HFB301001)**  
- **HFB200604**  
- **HFB3024**